Caveolin-1 single-nucleotide polymorphism and arterial stiffness in non-dialysis chronic kidney disease

Abstract

This replicated study suggests potential utility of the studied CAV1 SNP as a genetic biomarker in CKD and a role for CAV1 in the development of arteriosclerosis in this setting. Further studies are warranted to further explore the basic science driving these clinical observations.